Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

SungGi Chi

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 2, 2024
[Expectations and challenges for clinical application of cancer genome panels in acute myeloid leukemia]SungGi Chi
International Journal of Hematology|August 15, 2015
Disseminated intravascular coagulation in non-Hodgkin lymphomaSungGi Chi, Takayuki Ikezoe
International Journal of Molecular Sciences|February 25, 2023
The Immuno-Oncology and Genomic Aspects of DNA-Hypomethylating Therapeutics in Acute Myeloid LeukemiaAkiko Urabe, SungGi Chi, Yosuke Minami
International Journal of Molecular Sciences|March 6, 2021
Emerging Immunotherapy for Acute Myeloid LeukemiaRikako Tabata, SungGi Chi, Junichiro Yuda, et al.
Biomedicines|July 30, 2020
Mechanisms Underlying Resistance to FLT3 Inhibitors in Acute Myeloid LeukemiaMotoki Eguchi, Yosuke Minami, Ayumi Kuzume, et al.
International Journal of Molecular Sciences|August 6, 2020
Immune-Checkpoint Blockade Therapy in LymphomaAyumi Kuzume, SungGi Chi, Nobuhiko Yamauchi, et al.
International Journal of Hematology|May 9, 2022
FLT3-targeted treatment for acute myeloid leukemiaYasuyuki Arai, SungGi Chi, Yosuke Minami, et al.
Leukemia Research|October 23, 2017
In vitro studies on the role of recombinant human soluble thrombomodulin in the context of retinoic acid mediated APL differentiation syndromeShinsuke Kojima, Chie Nishioka, SungGi Chi, et al.
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|June 19, 2007
[Geriatric syndrome: slightly reduced visual and hearing impairments reduce activities daily living (ADL) and quality of life (QOL) in the community-dwelling elderly]Masanori Nishinaga, Sunggi Chi, Yuri Kazusa, et al.
International Journal of Hematology|October 9, 2013
Recombinant human soluble thrombomodulin is active against hemophagocytic lymphohistiocytosis associated with acquired immunodeficiency syndromeSungGi Chi, Takayuki Ikezoe, Asako Takeuchi, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 2, 2024
[Expectations and challenges for clinical application of cancer genome panels in acute myeloid leukemia]SungGi Chi
International Journal of Hematology|August 15, 2015
Disseminated intravascular coagulation in non-Hodgkin lymphomaSungGi Chi, Takayuki Ikezoe
International Journal of Molecular Sciences|February 25, 2023
The Immuno-Oncology and Genomic Aspects of DNA-Hypomethylating Therapeutics in Acute Myeloid LeukemiaAkiko Urabe, SungGi Chi, Yosuke Minami
International Journal of Molecular Sciences|March 6, 2021
Emerging Immunotherapy for Acute Myeloid LeukemiaRikako Tabata, SungGi Chi, Junichiro Yuda, et al.
Biomedicines|July 30, 2020
Mechanisms Underlying Resistance to FLT3 Inhibitors in Acute Myeloid LeukemiaMotoki Eguchi, Yosuke Minami, Ayumi Kuzume, et al.
International Journal of Molecular Sciences|August 6, 2020
Immune-Checkpoint Blockade Therapy in LymphomaAyumi Kuzume, SungGi Chi, Nobuhiko Yamauchi, et al.
International Journal of Hematology|May 9, 2022
FLT3-targeted treatment for acute myeloid leukemiaYasuyuki Arai, SungGi Chi, Yosuke Minami, et al.
Leukemia Research|October 23, 2017
In vitro studies on the role of recombinant human soluble thrombomodulin in the context of retinoic acid mediated APL differentiation syndromeShinsuke Kojima, Chie Nishioka, SungGi Chi, et al.
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|June 19, 2007
[Geriatric syndrome: slightly reduced visual and hearing impairments reduce activities daily living (ADL) and quality of life (QOL) in the community-dwelling elderly]Masanori Nishinaga, Sunggi Chi, Yuri Kazusa, et al.
International Journal of Hematology|October 9, 2013
Recombinant human soluble thrombomodulin is active against hemophagocytic lymphohistiocytosis associated with acquired immunodeficiency syndromeSungGi Chi, Takayuki Ikezoe, Asako Takeuchi, et al.
Pageof 4